TY - JOUR
T1 - Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis
T2 - Results from a multicenter Italian experience
AU - Moscarella, Elisabetta
AU - Varricchio, Attilio
AU - Stabile, Eugenio
AU - Latib, Azeem
AU - Ielasi, Alfonso
AU - Tespili, Maurizio
AU - Cortese, Bernardo
AU - Calabrò, Paolo
AU - Granata, Francesco
AU - Panoulas, Vasileios F.
AU - Franzone, Anna
AU - Trimarco, Bruno
AU - Bonzani, Giulio
AU - Esposito, Giovanni
AU - Colombo, Antonio
N1 - Publisher Copyright:
© 2015 Elsevier Ireland Ltd. All rights reserved.
PY - 2015/9/15
Y1 - 2015/9/15
N2 - This multicenter experience sought to investigate the feasibility and safety of BVS for the treatment of ISR. From April 2012 to June 2014, a total of 315 patients (334 lesions) underwent PCI for ISR at the participating centers. Of those, 83 patients (90 lesions) received BVS. Procedural success was achieved in all patients. At a median of 7 (IQR 3-18) months follow-up, MACCE rate was 12%, TLR 7.7%, while one (1.1%) definite BVS-in-stent thrombosis was reported. The results of this multicenter experience suggest that BVS implantation for the treatment of coronary ISR is technically feasible and associated with favorable mid-term clinical results. These data could be considered hypothesis generating for a future randomized clinical trial.
AB - This multicenter experience sought to investigate the feasibility and safety of BVS for the treatment of ISR. From April 2012 to June 2014, a total of 315 patients (334 lesions) underwent PCI for ISR at the participating centers. Of those, 83 patients (90 lesions) received BVS. Procedural success was achieved in all patients. At a median of 7 (IQR 3-18) months follow-up, MACCE rate was 12%, TLR 7.7%, while one (1.1%) definite BVS-in-stent thrombosis was reported. The results of this multicenter experience suggest that BVS implantation for the treatment of coronary ISR is technically feasible and associated with favorable mid-term clinical results. These data could be considered hypothesis generating for a future randomized clinical trial.
KW - BVS
KW - DES
KW - Restenosis
KW - Stent
UR - http://www.scopus.com/inward/record.url?scp=84941662896&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84941662896&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2015.07.002
DO - 10.1016/j.ijcard.2015.07.002
M3 - Article
C2 - 26241643
AN - SCOPUS:84941662896
SN - 0167-5273
VL - 199
SP - 366
EP - 372
JO - International Journal of Cardiology
JF - International Journal of Cardiology
ER -